Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
06/20/1996 | CA2207429A1 Polyarylcarbamoylaza - and - carbamoylalkanedioic acids |
06/20/1996 | CA2165374A1 Restricted 9-cis-retenoids |
06/19/1996 | EP0717044A1 Thienopyridone derivatives, their preparation and their use as NMDA-receptor antagonists |
06/19/1996 | EP0717040A1 Thiazine or thiazepine derivatives which inhibit NOS |
06/19/1996 | EP0717037A1 Substituted 1H-imidazoles having alpha 2-agonistic and alpha 1-antagonistic activity |
06/19/1996 | EP0717034A1 Vitamin D compounds and method of preparing these compounds |
06/19/1996 | EP0716650A1 Indole and indoline derivatives as 5ht1d receptor antagonists |
06/19/1996 | EP0716649A1 5-arylindole derivatives |
06/19/1996 | EP0716648A1 New 9-chloro-prostaglandin derivatives |
06/19/1996 | EP0716611A1 Method to reduce myocardial injury during acute myocardial infarction |
06/19/1996 | EP0716609A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-$g(b) ACTIVITY |
06/19/1996 | EP0716603A1 Methods and compositions for inhibiting uridine secretion |
06/19/1996 | CN1124961A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists |
06/19/1996 | CN1124960A Indole derivatives as 5-HT1A and/or 5-HT2 ligands |
06/19/1996 | CN1124923A Endothelin receptor antagonists |
06/19/1996 | CN1124922A Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
06/18/1996 | US5527919 Process for the preparation of 1-[(1,1'-biphenyl]-4-YL]-methyl-1H-imidazole-5-carboxylic acids |
06/18/1996 | US5527817 N,n-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl) ethylamine; selective agonist of 5-ht1-like receptors; useful in treatment of migraines |
06/18/1996 | US5527814 Use of 2-amino-6-(trifluoromethoxy)benzothiazole for obtaining a medicament for the treatment of amyotrophic lateral sclerosis |
06/18/1996 | US5527809 Substituted imidazo[4,5-b]pyridines and benzimidazoles |
06/18/1996 | US5527804 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors or cholesterol absorption |
06/18/1996 | US5527789 Administering a ubiquinone to combat heart failure |
06/18/1996 | US5527778 Method for selective opening of abnormal brain tissue capillaries |
06/18/1996 | US5527521 Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications |
06/17/1996 | CA2165386A1 2-amino-1,3-thiazepines and their use as inhibitors of nitric oxide synthase |
06/16/1996 | CA2165129A1 Thienopyridones |
06/15/1996 | CA2165133A1 Substituted 1h-imidazoles |
06/15/1996 | CA2164916A1 Vitamin d compounds and method of preparing these compounds |
06/15/1996 | CA2155627A1 Thiazine- or thiazepine-derivatives |
06/13/1996 | WO1996017935A2 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
06/13/1996 | WO1996017868A1 A novel chemokine expressed in inflamed adenoid, its production and uses |
06/13/1996 | WO1996017866A1 Novel protein domain which binds tyrosine phosphorylated proteins |
06/13/1996 | WO1996017861A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
06/13/1996 | WO1996017845A1 Rapamycin 42-oximes and hydroxylamines |
06/13/1996 | WO1996017831A1 Uracil derivatives |
06/13/1996 | WO1996017610A1 Use of xanthine oxidase inhibitors as anti-ischaemic agents |
06/13/1996 | WO1996012697A3 Calcium receptor-active compounds |
06/13/1996 | CA2207269A1 Use of xanthine oxidase inhibitors as anti-ischaemic agents |
06/13/1996 | CA2207262A1 A novel chemokine expressed in inflamed adenoid, its production and uses |
06/13/1996 | CA2207036A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
06/13/1996 | CA2206965A1 Rapamycin 42-oximes and hydroxylamines |
06/13/1996 | CA2204144A1 Substituted tetra- and pentapeptide inhibitors of protein:farnesyl transferase |
06/12/1996 | EP0716087A1 Heterocyclic amides for control of the potassium channels |
06/12/1996 | EP0716082A1 Oxy-phenyl-(phenyl)glycinolamides substituted with a heterocycle having antiatherosclerotic activity |
06/12/1996 | EP0716077A1 Aromatically substituted omega amino alcanoic acid amides and alcanoic diamides and their use as renine inhibitors |
06/12/1996 | EP0715851A2 Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders |
06/12/1996 | EP0715849A1 A method of inhibiting endotoxin induced effects |
06/12/1996 | EP0715627A1 Indole derivatives as thromboxane a2 antagonists |
06/12/1996 | EP0715619A1 Inhibitors of tnf-alpha secretion |
06/12/1996 | EP0619819B1 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders |
06/12/1996 | EP0556322B1 Aminosulfonyl urea acat inhibitors |
06/12/1996 | EP0515420B1 Nitric acid esters of cyclohexanol derivatives |
06/12/1996 | EP0503044B1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof |
06/12/1996 | EP0422134B1 5-ht selective agents |
06/12/1996 | CN1124489A Tetracyclic compounds as dopamine agonists |
06/12/1996 | CN1124485A Novel 1-phenylalkanone 5-HT4 receptor ligands |
06/12/1996 | CN1124484A 3-(indol-3-YL) propenoic acid derivatives and as NMDA antagonists |
06/12/1996 | CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products |
06/12/1996 | CN1124453A Broiler ascites preventive and method of preventing ascites |
06/12/1996 | CN1124141A Xinmailong extract and Xinmailong medical preparation for curing angiocardiopath |
06/12/1996 | CN1124140A Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration |
06/12/1996 | CN1031999C Process for preparing 6-substituted-tetrahydrobenz |CD¨ indoles |
06/11/1996 | US5525723 Inhibitors of angiotensin converting enzyme, neutral endopeptidase |
06/11/1996 | US5525629 Inhibition of cytokine production |
06/11/1996 | US5525614 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin II receptor antagonist properties |
06/11/1996 | US5525613 Covalently coupled benzoylecgonine ecgonine and ecgonidine |
06/11/1996 | US5525604 4-aminopyrimidine derivatives |
06/11/1996 | US5525338 Detection and therapy of lesions with biotin/avidin conjugates |
06/11/1996 | US5525334 Method for vascular embolization |
06/09/1996 | CA2164571A1 Aromatically substituted w-amino-alkanoic acid amides and alkanoic acid diamides |
06/06/1996 | WO1996016981A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
06/06/1996 | WO1996016967A1 Hindered n-oxide esters of rapamycin and their use as medicaments |
06/06/1996 | WO1996016964A1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
06/06/1996 | WO1996016949A1 Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs |
06/06/1996 | WO1996016939A1 Perhydroisoindole derivatives as antagonists of substance p |
06/06/1996 | WO1996016934A1 Substituted biphenyl compounds for the treatment of inflammation |
06/06/1996 | WO1996016931A1 Metalloproteinase inhibitors |
06/06/1996 | WO1996016671A1 New antithrombotic formulation, process for its manufacturing, and use thereof |
06/06/1996 | WO1996016653A1 Immunorejection inhibitor |
06/06/1996 | WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
06/06/1996 | WO1995032298A3 Safe vectors for gene therapy |
06/06/1996 | CA2206459A1 New antithrombotic formulation, process for its manufacturing, and use thereof |
06/06/1996 | CA2206257A1 Substituted biphenyl compounds for the treatment of inflammation |
06/06/1996 | CA2205972A1 Metalloproteinase inhibitors |
06/06/1996 | CA2205577A1 Hindered n-oxide esters of rapamycin and their use as medicaments |
06/06/1996 | CA2164375A1 Heterocyclic amides |
06/05/1996 | EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands |
06/05/1996 | EP0714908A2 New 17-(3-imino-2-alkyl-propenyl)-5beta,14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
06/05/1996 | EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors |
06/05/1996 | EP0714660A1 Ranolazine and related piperazines for protecting skeletal muscles |
06/05/1996 | EP0714396A1 Vasocontrictive dihydrobenzopyran derivatives |
06/05/1996 | EP0714395A1 Vasoconstrictive substituted dihydropyranopyridines |
06/05/1996 | EP0714391A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists |
06/05/1996 | EP0714388A1 Vasoconstrictive substituted aryloxyalkyl diamines |
06/05/1996 | EP0714301A1 Use of n-alkylated 1,4-dihydropyridine dicarboxylic acid esters as medicaments |
06/05/1996 | EP0714299A1 Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists |
06/05/1996 | EP0714294A1 Pharmaceutical compositions comprising metal complexes |
06/05/1996 | EP0633780B1 Use of phenothiazine derivatives for treating ischaemia and/or hypoxia |
06/05/1996 | CN1124027A Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
06/05/1996 | CN1123678A Foot bathing lotion for lowering blood pressure |